GQG Partners’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-2,728
Closed -$373K 89
2021
Q3
$373K Buy
+2,728
New +$344K ﹤0.01% 78
2020
Q4
Sell
-2,695,352
Closed -$278M 69
2020
Q3
$278M Buy
2,695,352
+295,768
+12% +$30.9M 0.95% 35
2020
Q2
$243M Buy
2,399,584
+532,608
+29% +$47.6M 1.07% 31
2020
Q1
$126M Buy
+1,866,976
New +$116M 0.87% 33

Other funds holding DXCM

GQG Partners's DXCM Position: Q4 2021 in Review

GQG Partners sold out of DexCom (DXCM) in Q4 2021, closing a stake of 2,728 shares — an estimated $373K sold.

GQG Partners first reported a position in DXCM in Q1 2020 and held it in 4 quarters. The position peaked at $278M in Q3 2020. 930 funds tracked by Wall St. Rank hold DXCM as of Q4 2021.

  • GQG Partners reported no remaining DexCom position as of Q4 2021 after selling out during the quarter.
  • GQG Partners sold 2,728 DexCom shares in Q4 2021, an estimated $373K.
  • GQG Partners first reported a position in DexCom in Q1 2020 and held it in 4 quarters.
  • GQG Partners's DexCom position peaked at $278M in Q3 2020.
  • 930 funds tracked by Wall St. Rank held DexCom as of Q4 2021.

Based on GQG Partners's 13F filing for Q4 2021, filed 14 Feb 2022.